Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase (Q56897712)

2

0 references

Daiki Morisaki

3

0 references

Makoto Muroi

4

0 references

Hiroyuki Osada

Experimental Cell Research

5

0 references

language of work or name

English

0 references

publication date

10 September 2008

0 references

published in

0 references

volume

314

0 references

issue

15

0 references

page(s)

2834-45

0 references

cites work

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Order out of chaos: assembly of ligand binding sites in heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Roles of heparan-sulphate glycosaminoglycans in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparanase, a potential regulator of cell-matrix interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparanase as a molecular target of cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Expression of heparanase in human tumor cell lines and human head and neck tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Role of promoter methylation in regulation of the mammalian heparanase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Human heparanase. Purification, characterization, cloning, and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Cloning and functional expression of a human heparanase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparanase processing by lysosomal/endosomal protein preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Secretion of Heparanase Protein Is Regulated by Glycosylation in Human Tumor Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Involvement of disulfide bond formation in the activation of heparanase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Novel heparan sulfate mimetic compounds as antitumor agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Two heparanase splicing variants with distinct properties are necessary in early Xenopus development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

N-(4-nitro-2,1,3-benzoxadiazoyl-7-yl)-N-methyl-2-aminoacetohydrazide (NBD-CO-Hz) as a precolumn fluorescent derivatization reagent for carboxylic acids in high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

A simple method for displaying the hydropathic character of a protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

Analysis of the membrane topology for transmembrane domains 7-12 of the human reduced folate carrier by scanning cysteine accessibility methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004

A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.004